Medicines

Hydroxychloroquine (Plaquenil): Uses, How It Works, Side Effects

Photo of author

By Health Linear Editorial Team

Updated

Hydroxychloroquine

Hydroxychloroquine (brand name Plaquenil) is an antimalarial medicine that’s now mostly used to treat lupus and rheumatoid arthritis.

  • Approved uses: in the US it’s approved for systemic and discoid lupus, rheumatoid arthritis, and malaria prevention and treatment where the parasite is still sensitive. Doctors also use it off-label for other autoimmune conditions such as Sjögren’s syndrome.
  • How it works: it calms the overactive immune system by changing how immune cells process signals, so it takes weeks to months to work fully.
  • Main long-term risk: damage to the retina of the eye, which is why doses are kept at or below 5 mg per kg of body weight a day and yearly eye screening starts after five years.
  • COVID-19: it doesn’t treat or prevent COVID-19. The large RECOVERY trial found no benefit, and the FDA revoked its emergency authorization in 2020.

This is general information, not medical advice. Don’t start, stop or change hydroxychloroquine without your prescriber. Stopping can cause lupus flares.

Hydroxychloroquine at a glance

Details
Brand namePlaquenil (also many generics, sold as hydroxychloroquine sulfate 200 mg tablets)
Drug classAntimalarial; disease-modifying antirheumatic drug (DMARD)
FDA-approved usesSystemic lupus erythematosus, chronic discoid lupus, rheumatoid arthritis, malaria (prevention and treatment)
Common off-label usesSjögren’s syndrome, some other autoimmune and skin conditions, antiphospholipid syndrome (as an add-on)
Typical lupus or RA dose200 to 400 mg daily, kept at or below 5 mg/kg of actual body weight a day
Time to workWeeks to months (often 2 to 6 months for full effect)
Key safety checksBaseline eye exam, then yearly retinal screening after 5 years (sooner if at higher risk)
PregnancyGenerally continued in lupus pregnancy. Stopping can trigger flares

What hydroxychloroquine is used for

Lupus (systemic and discoid)

Hydroxychloroquine is a cornerstone of lupus treatment, and major guidelines recommend it for nearly everyone with systemic lupus unless there’s a reason not to use it. Long-term use is linked to fewer flares, less organ damage, better survival, and lower risk of blood clots. It’s also used for chronic discoid lupus, a skin form. For many people with lupus, it’s a lifelong background medicine even when they feel well.

Rheumatoid arthritis

For RA, hydroxychloroquine is a milder conventional DMARD. It’s often used for mild disease, or in combination with methotrexate and sulfasalazine (“triple therapy”), which works about as well as some biologic combinations for many patients. It doesn’t stop joint damage on its own as strongly as methotrexate.

Malaria

Hydroxychloroquine can prevent and treat malaria caused by parasites that are still sensitive to chloroquine. But chloroquine resistance is now widespread in most malaria regions, especially for Plasmodium falciparum, so it’s rarely the right choice for travellers. Travel clinics usually recommend other medicines, such as atovaquone-proguanil, doxycycline or mefloquine, depending on the destination. It doesn’t prevent relapses of P. vivax or P. ovale malaria, which need another medicine, primaquine or tafenoquine.

Other uses

Specialists sometimes use it off-label for Sjögren’s syndrome, some skin conditions (such as certain types of hair loss and photosensitive rashes), juvenile arthritis, and as an add-on in antiphospholipid syndrome, particularly in pregnancy. Evidence varies by condition.

How hydroxychloroquine works

Hydroxychloroquine is a weak base that accumulates inside acidic compartments of cells called lysosomes and endosomes. Raising the pH there interferes with several immune processes:

  • It reduces how immune cells process and present antigens, dampening the activation of T cells.
  • It blocks signalling through toll-like receptors (especially TLR7 and TLR9), which detect DNA and RNA and are overactive in lupus. This lowers production of type I interferon and other inflammatory chemicals.
  • It reduces the release of inflammatory cytokines such as IL-1, IL-6 and TNF.

Against malaria, it builds up in the parasite’s acidic digestive vacuole and blocks its ability to detoxify heme from the blood it digests, so toxic heme poisons the parasite. Unlike strong immunosuppressants, hydroxychloroquine doesn’t meaningfully increase infection risk, which is one reason it’s so widely used.

Dosing

UseTypical adult dosing (FDA label)
Rheumatoid arthritisStart 400 to 600 mg daily; then 200 to 400 mg daily (once daily or split into two doses)
Lupus200 to 400 mg daily
Malaria prevention400 mg once a week, starting 2 weeks before travel, continuing weekly while there and for 4 weeks after leaving
Malaria treatment (uncomplicated, sensitive strains)800 mg, then 400 mg at 6, 24 and 48 hours (total 2,000 mg)
ChildrenWeight-based; tablets aren’t suitable for children under 31 kg

The 5 mg/kg rule: the 2016 American Academy of Ophthalmology guideline recommends a maximum daily dose of 5 mg/kg of actual body weight to reduce retinal risk. For a 60 kg (132 lb) person, that’s 300 mg a day. Doses are often given as 400 mg some days and 200 mg others to average out correctly. Lower doses may be used with kidney disease.

How to take it: with food or milk to reduce stomach upset. Swallow tablets whole. Keep it away from children, because hydroxychloroquine overdose is particularly dangerous in young children, and even a few tablets can be fatal.

Retinal toxicity and eye screening

The most important long-term risk is damage to the retina (hydroxychloroquine retinopathy). It can cause permanent loss of central or ring-shaped vision, and it can keep progressing for a while even after the drug is stopped. That’s why it should be caught early, before symptoms appear.

  • How common: according to the 2016 guideline, at recommended doses the risk is under 1% for the first 5 years and under 2% up to 10 years, but rises to almost 20% after 20 years.
  • Risk factors: doses over 5 mg/kg/day, use for more than 5 years, kidney disease, tamoxifen use, and existing retinal or macular disease.
  • Screening: a baseline eye exam within the first year, then annual screening after 5 years for people at normal risk, or sooner and yearly from the start for those with risk factors. Screening uses automated visual field testing and spectral-domain optical coherence tomography (OCT). In Asian patients, damage often begins outside the central macula, so wider scans are needed.

Side effects

Common, usually mild: nausea, stomach upset, diarrhea, headache, dizziness, and skin rash or itching. These often settle, and taking the dose with food helps.

Less common or serious:

  • Retinopathy (see above).
  • Heart rhythm effects: QT prolongation and, rarely, dangerous arrhythmias, especially with other QT-prolonging drugs or existing heart disease. Rarely, long-term use can cause cardiomyopathy.
  • Low blood sugar, sometimes severe, particularly in people taking diabetes medicines.
  • Skin reactions, including rare severe reactions (Stevens-Johnson syndrome, DRESS). Skin darkening (blue-grey pigmentation) can occur with long-term use.
  • Neuropsychiatric effects: mood changes, anxiety, sleep problems, and rarely psychosis or suicidal thoughts.
  • Muscle weakness (myopathy) and nerve problems with long-term use.
  • Blood problems (low blood counts), and hemolysis in people with G6PD deficiency (rare).
  • Worsening of psoriasis or porphyria.

Who should not take it, or needs extra care

  • Known allergy to hydroxychloroquine or similar 4-aminoquinolines (chloroquine).
  • Existing retinal or visual field changes from any cause, unless the benefit clearly outweighs the risk.
  • Heart conditions with QT prolongation, or uncorrected low potassium or magnesium.
  • Kidney or liver disease (dose adjustment and monitoring).
  • Psoriasis, porphyria, G6PD deficiency, diabetes, or epilepsy (it may lower the seizure threshold).

Drug interactions

  • QT-prolonging drugs (some antibiotics such as azithromycin and fluoroquinolones, antipsychotics, citalopram, ondansetron, antiarrhythmics) add to heart rhythm risk.
  • Diabetes medicines (insulin, sulfonylureas) raise hypoglycemia risk, so blood sugar may need closer monitoring.
  • Digoxin levels can rise.
  • Antacids and kaolin reduce absorption. Separate them by at least 4 hours.
  • Cimetidine can raise hydroxychloroquine levels.
  • Tamoxifen increases retinal risk.
  • Cyclosporine levels can increase.
  • Medicines that lower the seizure threshold and other antimalarials may add to seizure risk.

Tell your prescriber and pharmacist about every medicine and supplement you take. Our alcohol and medication interaction checker covers drinking with common medicines.

Pregnancy and breastfeeding

Hydroxychloroquine is one of the medicines lupus specialists most often continue through pregnancy. Stopping it is linked to more lupus flares, which are risky for both mother and baby. Large studies haven’t shown a meaningful increase in birth defects at usual doses. In women with certain antibodies (anti-Ro/SSA), it may also reduce the risk of congenital heart block in the baby. It passes into breast milk in small amounts and is considered compatible with breastfeeding. Decisions should always be made with the rheumatology and obstetric team.

Hydroxychloroquine and COVID-19: what actually happened

Early in 2020, lab studies and small, poorly controlled reports suggested hydroxychloroquine might help against COVID-19. In March 2020, the FDA issued an emergency use authorization (EUA). Large randomized trials then tested it properly:

  • The UK RECOVERY trial, published in the New England Journal of Medicine in 2020, randomized thousands of hospitalized patients and found that hydroxychloroquine did not reduce deaths. Patients taking it had a longer hospital stay and a higher risk of needing a ventilator or dying.
  • Other large trials, including the WHO Solidarity trial, and prevention studies also found no benefit.
  • The FDA revoked the EUA in June 2020, citing lack of benefit and safety concerns, including heart rhythm problems.

Some observational studies at the time, including a widely publicized one from a US hospital system, reported benefits, but observational studies can’t separate the drug’s effect from differences in who received it. The randomized trials are the reliable evidence. A side effect of the hype was temporary shortages that affected people with lupus and RA who depend on the drug.

Other monitoring while on hydroxychloroquine

  • Blood tests: a baseline full blood count, kidney function and liver tests are common. Repeat tests depend on the condition being treated and other medicines. Kidney function matters because reduced clearance raises both drug levels and retinal risk.
  • ECG: may be checked before starting or during treatment in people with heart disease, other QT-prolonging medicines, or low potassium or magnesium.
  • Blood sugar: people with diabetes may need closer glucose monitoring when starting, because of hypoglycemia risk.
  • Blood levels: some lupus specialists measure hydroxychloroquine blood levels to check adherence, since low levels are linked to more flares.

Missed doses and stopping

Hydroxychloroquine has a very long half-life. It builds up in tissues and stays in the body for weeks, so missing a single dose isn’t dangerous. Take it when you remember, unless it’s nearly time for the next dose, and don’t double up. Stopping is a different matter. In lupus, discontinuing hydroxychloroquine is linked to a higher risk of flares over the following months, so it should only be stopped or reduced with your specialist. When long-term users reach 10 to 20 years of treatment, some specialists review whether a lower dose is appropriate, given the rising retinal risk.

Practical tips if you take hydroxychloroquine

  • Give it time. Benefits for lupus and RA build over 2 to 6 months.
  • Keep your eye screening appointments, and tell your eye doctor you take it.
  • Report vision changes, such as blurring, missing areas, or trouble reading or seeing faces, without waiting.
  • Ask your prescriber to check the dose against your current weight if your weight changes significantly.
  • Report palpitations, fainting, symptoms of low blood sugar, or mood changes.
  • Store tablets out of children’s reach.
  • Don’t stop suddenly without advice if you have lupus.

For other immune-modifying medicines, see our guide to azathioprine. If you take a proton pump inhibitor or antacid regularly, separate doses as advised. Our PPI comparison tool explains acid-reducing options.

Frequently asked questions

What is hydroxychloroquine used for?

Mainly lupus and rheumatoid arthritis. It’s also approved for preventing and treating malaria where parasites are still sensitive, and used off-label for some other autoimmune conditions.

How long does hydroxychloroquine take to work?

Usually several weeks, with the full benefit taking 2 to 6 months for lupus and arthritis.

Does hydroxychloroquine damage your eyes?

It can damage the retina with long-term use. The risk is under 1% in the first 5 years at recommended doses, but rises with dose and duration. That’s why dosing is kept at or below 5 mg/kg/day and yearly screening starts after 5 years.

Does hydroxychloroquine work for COVID-19?

No. Large randomized trials, including RECOVERY, found no benefit, and the FDA revoked its emergency use authorization in June 2020.

Can I take hydroxychloroquine while pregnant?

It’s usually continued in lupus pregnancy, because stopping it raises flare risk, and studies haven’t shown meaningful harm at usual doses. Decide with your specialist team.

References

About this article

Written by the Health Linear Editorial Team from primary sources such as FDA prescribing information, DailyMed, NIH and peer-reviewed studies, which are linked in the article. Last updated October 28, 2026.

Read our editorial process and medical disclaimer. Spotted an error? Tell us and we will correct it.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.